THERAFECTIN
USPTO Trademark Record · Serial No. 74061543
Trademark details
It was initially claimed by Boston Life Sciences, Inc. on 19900522.
That brand applies to the following goods and services:pharmaceutical preparations, namely, amiprilose hydrochloride, for the treatment of rheumatoid arthritis, skin diseases, and autoimmune diseases.
Currently that trademark is represented by trademark attorney(s): Robert D. Bajefsky.
You can learn more about that trademark on the USPTO website: View the USPTO record
Services available
Questions about this trademark?
If you have questions or issues related to the THERAFECTIN trademark — or to trademarks in general — our trademark attorneys can help. No appointment needed: call us or request a free estimate.
Register a Trademark Get a Free Estimate
